Filter posts

Hits to Patients Keep on Coming

At a time when prescription drug prices and spending are remarkably stable, patients are getting …

On the President’s Drug Cost Plan, Three Important Concerns

Part 2. Upending Access in Medicare Part B program This week, BIO launched a three-part …

Cancer Docs Weigh in on Medicare Part B Demo

This week, American Society of Clinical Oncology (ASCO) President Daniel Hayes, MD and CEO Clifford …

What They’re Saying about the Medicare Part B Demo

Back in March, CMS’s Center for Medicare and Medicaid Innovation (CMMI) proposed a sweeping demonstration …

Morning Consult: Medicare’s Deadly Cancer Care Gamble

Today in Morning Consult, cancer survivor and health economist Jennifer Hinkel writes about the threat …

Immune Deficiency Foundation: Medicare’s “one size fits all” drug demo is wrong for seniors wi...

Writing yesterday in The Hill, Immune Deficiency Foundation President Marcia Boyle explains the potential harm posed …

Patient and provider groups ask CMS: Don’t turn back the clock on rheumatic disease care

Writing today in The Hill, Ann Palmer of the Arthritis Foundation and Joan Von Feldt …

Morning Consult: Medicare’s Flawed Part B Drug Experiment Could Harm Patients

In today’s Morning Consult, the Community Oncology Alliance’s Rose Gerber has an excellent piece detailing …